𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Frequent inactivation of SPARC by promoter hypermethylation in colon cancers

✍ Scribed by Eungi Yang; Hyun Ju Kang; Kwi Hye Koh; Hwanseok Rhee; Nam Kyu Kim; Hoguen Kim


Book ID
102862537
Publisher
John Wiley and Sons
Year
2007
Tongue
French
Weight
582 KB
Volume
121
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Epigenetic modification of gene expression plays an important role in the development of human cancers. The inactivation of SPARC through CpG island methylation was studied in colon cancers using oligonucleotide microarray analysis and methylation specific PCR (MSP). Gene expression of 7 colon cancer cell lines was evaluated before and after treatment with the demethylating agent 5‐aza‐2′‐deoxycytidine (5Aza‐dC) by oligonucleotide microarray analysis. Expression of SPARC was further examined in colon cancer cell lines and primary colorectal cancers, and the methylation status of the SPARC promoter was determined by MSP. SPARC expression was undetectable in 5 of 7 (71%) colorectal cancer cell lines. Induction of SPARC was demonstrated after treatment with the demethylating agent 5Aza‐dC in 5 of the 7 cell lines. We examined the methylation status of the CpG island of SPARC in 7 colon cancer cell lines and in 20 test set of colon cancer tissues. MSP demonstrated hypermethylation of the CpG island of SPARC in 6 of 7 cell lines and in all 20 primary colon cancers, when compared with only 3 of 20 normal colon mucosa. Immunohistochemical analysis showed that SPARC expression was downregulated or absent in 17 of 20 colon cancers. A survival analysis of 292 validation set of colorectal carcinoma patients revealed a poorer prognosis for patients lacking SPARC expression than for patients with normal SPARC expression (56.79% vs. 75.83% 5‐year survival rate, p = 0.0014). The results indicate that epigenetic gene silencing of SPARC is frequent in colon cancers, and that inactivation of SPARC is related to rapid progression of colon cancers. © 2007 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Frequent epigenetic inactivation of RIZ1
✍ Yasuhiro Oshimo; Naohide Oue; Yoshitsugu Mitani; Hirofumi Nakayama; Yasuhiko Kit 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 213 KB

## Abstract The retinoblastoma protein‐interacting zinc finger gene, __RIZ1__ (GenBank accession number U17838), is involved in chromatin‐mediated gene expression and is also a target for frameshift mutation in microsatellite‐unstable cancers. Methylation of the __RIZ1__ promoter CpG island has bee

Inactivation of helicase-like transcript
✍ Wai K. Leung; Jun Yu; Alfa H.C. Bai; Michael W.Y. Chan; Ka-Kui Chan; Ka-Fai To; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB

## Abstract Helicase‐like transcription factor (__HLTF__), a member of the SWI/SNF (mating type switching/sucrose nonfermenting) chromatin‐remodeling complex, is recently found to be inactivated by promoter hypermethylation in human colorectal cancer. However, the role of this putative tumor suppre